You are not logged in. This means
you CAN ONLY VIEW reports that were published prior to Tuesday, February 18, 2025. You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
MIDDAY BREAKOUTS REPORT - MONDAY, MARCH 30TH, 2020
Previous Mid Day Report Next Mid Day Report >>>
|
DOW 22023.52 386.74 (1.79%) | NASDAQ 7683.68 181.3 (2.42%) | S&P 500 2599.81 58.34 (2.30%)
|
Time of Screening :
3/30/2020 12:07:52 PM Report Released :
3/30/2020 12:40:09 PM Price is:
Above 52W High and Less Than 52W High
but within 15% of the 52 Week High Volume Is:
At least 45% of 50 Day Average at
the time of the screening.
More details about this report...
At around
mid-way through each trading day we run
a screen against our database of
high-ranked stocks, searching for
possible buy candidates that are trading
at or near their 52-week high on above
average volume. The results of that
screen are split into the two sections
you see below. The first, titled
"TODAY's FEATURED STOCKS" shows stocks
that our experts have recently
identified as among the strongest candidates to
consider. Stocks highlighted in yellow
are the most timely and noteworthy, so
particular attention and prompt action
may be appropriate. The second section,
titled "TODAY's BREAKOUT SCREEN" shows
the remainder of stocks meeting today's
screen parameters. Our experts have
reviewed and included notes on these
stocks as well, but found that they may
not match up as favorably.
|
Y - Today's strongest
candidates
highlighted
by our staff
of experts.
|
|
G - Previously featured in
this report as yellow and
now may no longer be buyable
under the guidelines.
|
|
|
NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.
|
|
 |
Symbol - Exchange - Industry Group Company Name |
Last |
Chg |
Day High |
52 WK Hi |
% From Hi |
Volume % DAV |
DAV |
ABT
- NYSE - DRUGS - Drug Manufacturers - Major
Abbott Laboratories
|
$79.89 |
+5.33
7.15%
|
$84.40
|
$92.45
|
-13.59% |
27,963,555 343.96%
|
8,130,000
|
Most Recent Note for ABT - 3/30/2020 12:11:21 PM
Rebounded to challenge its 200 DMA line ($84) with a gap up and big volume-driven gain today following approval of a rapid coronavirus test. Reported earnings +17% on +7% sales revenues for the Dec '19 quarter versus the year ago period. Prior quarterly comparisons versus the year ago periods were below the +25% minimum guideline (C criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AMZN
- NASDAQ - INTERNET - Internet Software & Services
Amazon.com Inc
|
$1,963.87 |
+63.77
3.36%
|
$1,973.63
|
$2,185.95
|
-10.16% |
2,913,975 49.34%
|
5,906,000
|
Most Recent Note for AMZN - 3/30/2020 12:14:02 PM
Rebounding above its 50 DMA line ($1,946) today, however it still faces resistance due to overhead supply up to the $2,185 level. Prior mid-day reports cautioned members - "Reported earnings +7% on +21% sales revenues for the Dec '19 quarter, it 3rd quarterly comparison below the +25% minimum earnings guideline (C criteria), not a match with the fact-based investment system's fundamental guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BCPC
- NASDAQ - CHEMICALS - Agricultural Chemicals
Balchem Corp
|
$97.00 |
+1.72
1.81%
|
$98.00
|
$113.93
|
-14.86% |
58,973 48.34%
|
122,000
|
Most Recent Note for BCPC - 3/30/2020 12:14:43 PM
This Chemicals - Specialty firm reported earnings +14% on +2% sales revenues for the Dec '19 quarter and fundamental concerns remain.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CVBF
- NASDAQ - BANKING - Regional - Pacific Banks
C V B Financial Corp
|
$19.96 |
+0.74
3.85%
|
$20.09
|
$22.23
|
-10.21% |
582,709 65.33%
|
892,000
|
Most Recent Note for CVBF - 3/30/2020 12:16:41 PM
New CEO as of 3/16/20. Quarterly and annual earnings history (C and A criteria) has not been a match with the fundamental guidelines of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DGICA
- NASDAQ - Insurance-Prop/Cas/Titl
Donegal Group Inc Cl A
|
$14.50 |
+0.77
5.61%
|
$14.50
|
$15.43
|
-6.03% |
16,348 58.39%
|
28,000
|
Most Recent Note for DGICA - 3/30/2020 12:17:30 PM
Prior quarterly sales revenues and earnings growth has not been strong and steady. Annual earnings (A criteria) history also has been up and down.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DOCU
- NASDAQ - Computer Sftwr-Enterprse
Docusign Inc
|
$86.77 |
+4.20
5.09%
|
$88.50
|
$92.55
|
-6.25% |
2,473,573 93.98%
|
2,632,000
|
Most Recent Note for DOCU - 3/30/2020 12:22:52 PM
Gapped up today for a volume-driven gain and very little resistance remains due to overhead supply up to the $92 level. Consolidating above its 50 DMA line ($81.40) after finding support at its 200 DMA line ($66). Earnings history included a -67% comparison in the Jul '19 quarter versus the year ago period, but otherwise results have been strong.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ELMD
- AMEX - Medical-Systems/Equip
Electromed Inc
|
$12.10 |
+0.07
0.58%
|
$12.84
|
$13.60
|
-11.03% |
59,419 52.12%
|
114,000
|
Most Recent Note for ELMD - 3/30/2020 12:23:24 PM
Rebounded to challenge its 52-week high. Found prompt support near its 200 DMA line after an abrupt pullback. Reported earnings +250% on +7% sales revenues for the quarter ended December 31, 2019 versus the year ago period, a 2nd strong quarterly comparison. Fundamental concerns remain as prior quarterly earnings increases were below the fact-based system's +25% minimum guideline (C criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
FCN
- NYSE - DIVERSIFIED SERVICES - Business/Management Services
F T I Consulting Inc
|
$118.02 |
+3.30
2.88%
|
$120.27
|
$135.51
|
-12.91% |
193,228 46.12%
|
419,000
|
Most Recent Note for FCN - 3/30/2020 12:24:40 PM
Reversed abruptly after hitting a new all-time high on 3/18/20. Found prompt support near its 200 DMA line ($108) again. Prior mid-day reports cautioned members - "Reported earnings -4% on +19% sales revenues for the Dec '19 quarter versus the year ago period, breaking a streak of 3 strong quarters above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) have improved steadily after a downturn in FY '12-14."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
FDS
- NYSE - COMPUTER SOFTWARE & SERVICES - Information & Delivery Service
Factset Research Sys Inc
|
$265.42 |
+10.71
4.20%
|
$272.38
|
$310.25
|
-14.45% |
229,420 53.35%
|
430,000
|
Most Recent Note for FDS - 3/30/2020 12:25:55 PM
Rebounding near its 200 DMA line ($270) today after an abrupt retreat. Reported earnings +5% on +4% sales revenues for the Feb '20 quarter. Prior quarterly earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Sales revenues and earnings history below guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NFLX
- NASDAQ - SPECIALTY RETAIL - Music & Video Stores
Netflix Inc
|
$372.40 |
+15.28
4.28%
|
$377.80
|
$393.52
|
-5.37% |
3,910,413 47.21%
|
8,283,000
|
Most Recent Note for NFLX - 3/30/2020 12:27:40 PM
Reported earnings +333% on +31% sales revenues for the Dec '19 quarter, its 2nd consecutive very strong quarter. Rebounded above its 200 DMA line ($322) and above its 50 DMA line ($357) following an abrupt slump. Still faces resistance due to overhead supply up to the $423 level. Went through a choppy consolidation since dropped from the Featured Stocks list on 7/30/18.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
QDEL
- NASDAQ - DRUGS - Diagnostic Substances
Quidel Corp
|
$96.26 |
+1.95
2.07%
|
$97.07
|
$100.42
|
-4.14% |
297,056 67.51%
|
440,000
|
Most Recent Note for QDEL - 3/30/2020 12:29:34 PM
This San Diego, CA based maker of rapid diagnostic tests for infectious diseases is challenging its all-time high with today's 3rd consecutive volume-driven gain. It has earned a high Earnings Per Share rating of 95. Reported earnings +23% on +15% sales revenues for the Dec '19 quarter and prior quarterly earnings comparisons were below the +25% minimum guideline (C criteria). Annual earnings (A criteria) history include a slight downturn in FY '19 following strong earnings growth in FY '17 and '18.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
RMD
- NYSE - HEALTH SERVICES - Medical Appliances & Equipment
Resmed Inc
|
$152.64 |
+10.69
7.53%
|
$155.99
|
$177.99
|
-14.24% |
402,816 49.12%
|
820,000
|
Most Recent Note for RMD - 3/30/2020 12:34:06 PM
Rebounding impressively after an abrupt slump below its 200 DMA line ($143). Reported earnings +21 on +13% sales revenues for the Dec '19 quarter, its 5th comparison below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) growth after a downturn in FY '15 has been slow and steady, not a great match with the winning models of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
RNG
- NYSE - Computer Sftwr-Enterprse
RingCentral Inc Cl A
|
$247.22 |
+8.25
3.45%
|
$256.60
|
$252.85
|
-2.23% |
1,101,875 72.02%
|
1,530,000
|
Most Recent Note for RNG - 3/30/2020 12:36:47 PM
Hitting new all-time highs following an abrupt slump in recent weeks that briefly undercut its 200 DMA line ($164). Last noted with caution in the 2/28/20 mid-day report - "Reported earnings -4% on +34% sales revenues for the Dec '19 quarter. Earnings increases were below the +25% minimum guideline in the Mar, Jun, and Sep '19 quarters versus the year ago periods although sales revenues growth remained strong. Annual earnings growth has been strong since turning a profitable FY '16 after shrinking losses in prior years."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TTWO
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Technical & System Software
Take-Two Interactv Sftwr
|
$116.17 |
+4.47
4.00%
|
$119.36
|
$135.70
|
-14.39% |
1,397,952 58.91%
|
2,373,000
|
Most Recent Note for TTWO - 3/30/2020 12:39:07 PM
Reported strong earnings increases in the Sep and Dec '19 quarters versus the year ago periods. Erratic sales revenues growth is a concern. With respect to the C and A criteria, its prior earnings history has been erratic and below the fact-based system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ZM
- NASDAQ - Computer Sftwr-Enterprse
Zoom Video Comm Cl A
|
$157.94 |
+6.24
4.11%
|
$161.69
|
$164.94
|
-4.25% |
7,887,887 83.35%
|
9,464,000
|
Most Recent Note for ZM - 3/30/2020 12:40:05 PM
Perched near its all-time high after a noted spurt volume-driven gains, and it is very extended from any sound base. Completed its $36.00 IPO on 4/18/19. Limited annual history (A criteria) is a concern. Reported earnings +275% on +78% sales revenues for the Jan '20 quarter. Prior quarterly comparisons also showed very strong sales revenues and great earnings increases versus the year ago periods.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
We are not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to FactBasedInvesting.com c/o Premium
Member Services 665 S.E. 10 Street, Suite 201
Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.
We appreciate any feedback
members may wish to send via the inquiry form
here.
|
|